American Medical Association

AMA Opioid Task Force 2018 Progress Report
AMA
AMA Fact Sheet: PDMP use increases from 61M to more than 300M from 2014-2017
Download
Promote Safe Storage and Disposal of Opioids and all Medications
Learn More
Help Save Lives: Co-Prescribe Naloxone to Patients at Risk of Overdose
Learn More
Thinking of Prescribing an Opioid? Did You Check Your State Prescription Drug Monitoring Program?

The AAP has been a member and active participant in the AMA’s Task Force to Reduce Opioid Abuse. The AAP is involved in the task force’s efforts to:
• educate physicians about safe opioid prescribing practices;
• educate state policymakers about the importance of effective prescription drug monitoring programs (PDMPs);
• educate physicians about the importance of using PDMPs; and
• encourage widespread community access of naloxone.

Learn More
AMA Opioid Task Force naloxone recommendations

Updated August 2017

Download
AMA Opioid Task Force 2018 Progress Report
Download
Selected quotes from recent AMA testimony, interviews and op-eds
Download
2012-2016 National and state-by-state reductions in retail filled opioid prescriptions

IMS Health

Download
The AMA Urges Removing All Barriers to Treatment for Substance Use Disorder
Download
Be Part of the Solution

Join the AMA today and help us lead the effort to reverse the nation’s opioid epidemic.